In a move that reshapes access to COVID-19 vaccines, the FDA now requires clinical trials to prove benefits for low-risk groups, while limiting vaccine availability to adults over 65 and those with risk factors like asthma and diabetes.
Author Archives: The Conversation
The Conversation is a nonprofit, independent news organization dedicated to unlocking the knowledge of experts for the public good. We publish trustworthy and informative articles written by academic experts for the general public and edited by our team of journalists.
